New combo diabetes pill tested in healthy volunteers
NCT ID NCT07519265
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a new single pill that combines two diabetes drugs (chiglitazar and metformin) works the same as taking them separately. It involves 64 healthy adults who will take both versions and have their blood levels measured. The goal is to see if the combo pill is a safe and effective alternative for people with type 2 diabetes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Chiglitazar and metformin extended-release fixed-dose combination tablet
- What this could lead to
- If successful, this could lead to a simpler, single-pill option for people with type 2 diabetes, making it easier to take their medication.
- What could go wrong
- This is an early-stage study in healthy people, not those with diabetes. It only checks if the combo pill is absorbed similarly, not if it works better or has fewer side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for T2DM (TYPE 2 DIABETES MELLITUS) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can an Anti-Inflammatory diet tame type 2 diabetes?
- New diabetes combo pill aims to beat single drugs in major trial
- New combo therapy aims to improve diabetes management
- New triple therapy aims to protect kidneys in diabetes patients
- New diabetes pill put to the test: does food change how it works?
- New Triple-Drug diabetes pill aims for better blood sugar control